SEC Company Response from Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685) (VTGN) — Mar 23, 2021
Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685)
Date: March 23, 2021 · CIK: 0001411685 · Accession: 0001654954-21-003132
AI Filing Summary & Sentiment
File numbers found in text: 333-254299
Letter
VIA EDGAR United States Securities and Exchange Commission Attention: Mr. Jeff Gabor VistaGen Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-254299)
RE:
Dear Mr. Gabor,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 10:00 a.m. Eastern Standard Time on Friday, March 26, 2021, or as soon as practicable thereafter.
Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Ms. Jessica R. Sudweeks at (619) 272-7063, to confirm the exact time at which the Registration Statement was declared effective.
Very truly yours,
VISTAGEN THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm vtgncorresp_mar2021 March 23, 2021 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Jeff Gabor RE: VistaGen Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-254299) Dear Mr. Gabor, Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 10:00 a.m. Eastern Standard Time on Friday, March 26, 2021, or as soon as practicable thereafter. Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Ms. Jessica R. Sudweeks at (619) 272-7063, to confirm the exact time at which the Registration Statement was declared effective. Very truly yours, VISTAGEN THERAPEUTICS, INC. /s/ Shawn K. Singh Shawn K. Singh Chief Executive Officer cc: Jessica Sudweeks Partner Disclosure Law Group, a Professional Corporation